Subclinical ILD is frequent and progresses across different connective tissue diseases
A. Hoffmann-Vold (Oslo, Norway), H. Andersson (Oslo, Norway), S. Reiseter (Oslo, Norway), H. Fretheim (Oslo, Norway), I. Barua (Oslo, Norway), T. Garen (Oslo, Norway), Ø. Midtvedt (Oslo, Norway), R. Gunnarsson (Oslo, Norway), M. Durhem (Oslo, Norway), M. Aaløkken (Oslo, Norway), Ø. Molberg (Oslo, Norway)
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Hoffmann-Vold (Oslo, Norway), H. Andersson (Oslo, Norway), S. Reiseter (Oslo, Norway), H. Fretheim (Oslo, Norway), I. Barua (Oslo, Norway), T. Garen (Oslo, Norway), Ø. Midtvedt (Oslo, Norway), R. Gunnarsson (Oslo, Norway), M. Durhem (Oslo, Norway), M. Aaløkken (Oslo, Norway), Ø. Molberg (Oslo, Norway). Subclinical ILD is frequent and progresses across different connective tissue diseases. 2973
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: